| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/11/2013 | US20130090297 Nutritional compositions |
| 04/11/2013 | US20130090296 Injectable formulation of a macrocyclic lactone and levamisole |
| 04/11/2013 | US20130090295 Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals |
| 04/11/2013 | US20130090291 Hemostatic compositions |
| 04/11/2013 | US20130089627 Method for treating a cancer caused by cancer stem cells |
| 04/11/2013 | US20130089626 Treating Cancer with ATR Inhibitors |
| 04/11/2013 | US20130089625 Compounds Useful as Inhibitors of ATR Kinase |
| 04/11/2013 | US20130089624 Compounds Useful as Inhibitors of ATR Kinase |
| 04/11/2013 | US20130089623 Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates |
| 04/11/2013 | US20130089617 Crystalline microparticles of a beta-agonist coated with a fatty acid |
| 04/11/2013 | US20130089616 Sustained-release nanoparticle compositions and methods for using the same |
| 04/11/2013 | US20130089615 Compositions of Jasmonate Compounds and Methods of Use |
| 04/11/2013 | US20130089612 R(+)-n-formyl-propargyl-aminoindan |
| 04/11/2013 | US20130089611 Rasagiline citramide |
| 04/11/2013 | US20130089610 R(+)-n-methyl-propargyl-aminoindan |
| 04/11/2013 | US20130089607 Once daily trospium chloride treatment method |
| 04/11/2013 | US20130089606 Methods and compositions for oral pharmaceutical therapy |
| 04/11/2013 | US20130089605 Method for Preparation of Highly Pure Asiaticoside Composition from Centella Asiatica and a Method of Use Thereof |
| 04/11/2013 | US20130089603 Compositions and methods for treating obesity and obesity-related conditions |
| 04/11/2013 | US20130089602 Encapsulated chelator |
| 04/11/2013 | US20130089601 Method for treating atherosclerosis |
| 04/11/2013 | US20130089598 Method of treating pulmonary disorders with liposomal amikacin formulations |
| 04/11/2013 | US20130089597 MicroRNA-130a,b as a Tumor Suppressor and Sensitizing Agent for Chemotherapy |
| 04/11/2013 | US20130089587 Personal Care Compositions and Methods of Making Same |
| 04/11/2013 | US20130089586 Method of Achieving Improved Hair Feel |
| 04/11/2013 | US20130089579 Combination of Hyaluronic Acid and Prilocaine |
| 04/11/2013 | US20130089577 Novel ester containing compositions and methods |
| 04/11/2013 | US20130089575 Pharmaceutical methods and topical compositions containing acitretin |
| 04/11/2013 | US20130089574 Method of preventive on-demand hormonal contraception |
| 04/11/2013 | US20130089555 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 04/11/2013 | US20130089551 Treatment of pulmonary edema |
| 04/11/2013 | US20130089538 Treating cancer by modulating mammalian sterile 20-like kinase 3 |
| 04/11/2013 | US20130089536 Pharmaceutical composition to prevent and treat alzheimer's disease comprising gcp ii mutant |
| 04/11/2013 | US20130089532 Adiponectin production accelerating composition |
| 04/11/2013 | US20130089520 Macrocyclic Inhibitors Of Hepatitis C Virus |
| 04/11/2013 | US20130089518 Novel pyrimidine derivatives |
| 04/11/2013 | US20130089512 Heteroaryl imidazolone derivatives as jak inhibitors |
| 04/11/2013 | US20130089510 Otic compositions for the treatment of infections of the internal and external ear in mammals |
| 04/11/2013 | US20130089508 Compositions for enhancing nail health |
| 04/11/2013 | US20130089505 Single vial formulation for medical grade cyanoacrylate |
| 04/11/2013 | US20130089504 Compositions Comprising Enzyme-Cleavable Hydromorphone Prodrug |
| 04/11/2013 | US20130089497 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 04/11/2013 | DE102011115690A1 Quetiapin enthaltende Formulierungen Quetiapine formulations containing |
| 04/11/2013 | DE102011114951A1 Molekülmischung, umfassend eine amphipathische Molekülsorte A, welche im hydrophilen Bereich elne positive Gesamtladung aufweist und eine amphipathische Molekülsorte B sowie ein Polyphenol C, Verfahren zur Herstellung der Molekülmischung und deren Verwendung Molecule mixture comprising an amphipathic molecule Type A, which in the hydrophilic region elne overall positive charge and comprises an amphipathic molecule Type B and a polyphenol C, process for the preparation of the molecular compound and the use thereof |
| 04/11/2013 | DE102004041612B4 Extraktion von Carotinen, Vitamin E und anderen in geringer Menge vorliegenden Bestandteilen aus natürlichen Fetten und Ölen mit überkritischen Fluiden Extraction of carotenes, vitamin E and other ingredients present in small amounts from natural fats and oils with supercritical fluids |
| 04/11/2013 | CA2851424A1 Prophylactic and post-acute use of progesterone to better outcomes associated with concussion |
| 04/11/2013 | CA2851405A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 04/11/2013 | CA2851398A1 Compositions for the treatment of dry eye |
| 04/11/2013 | CA2851258A1 Therapeutic sulfated polysaccharides, compositions thereof, and methods for treating patients |
| 04/11/2013 | CA2851243A1 Compositions for enhancing nail health |
| 04/11/2013 | CA2851187A1 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells |
| 04/11/2013 | CA2851082A1 1,3-substituted azetidine pde10 inhibitors |
| 04/11/2013 | CA2851037A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases |
| 04/11/2013 | CA2850995A1 Pharmaceutical compositions comprising 40-o-(2-hydroxy) ethyl-rapamycin |
| 04/11/2013 | CA2850932A1 Novel imidazole quinoline-based immune system modulators |
| 04/11/2013 | CA2850919A1 Choline composition |
| 04/11/2013 | CA2850853A1 Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist |
| 04/11/2013 | CA2850852A1 Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mtor inhibitors |
| 04/11/2013 | CA2850792A1 Compositions and methods for silencing aldehyde dehydrogenase |
| 04/11/2013 | CA2850779A1 Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication |
| 04/11/2013 | CA2850763A1 Novel quinoxaline inhibitors of pi3k |
| 04/11/2013 | CA2850723A1 Organonitro thioether compounds and medical uses thereof |
| 04/11/2013 | CA2850635A1 Methods for treating a stroke-related sensorimotor impairment using aminopyridines |
| 04/11/2013 | CA2850624A1 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| 04/11/2013 | CA2850296A1 Nanoparticles, process for preparation and use thereof as carrier for amphipatic of hydrophobic molecules in fields of medicine including cancer treatment and food related compounds |
| 04/11/2013 | CA2850223A1 Control of whole body energy homeostasis by microrna regulation |
| 04/11/2013 | CA2850082A1 Ethynyl derivatives as mglur5 allosteric modulators |
| 04/11/2013 | CA2850055A1 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein |
| 04/11/2013 | CA2850030A1 Personal care compositions and methods of making same |
| 04/11/2013 | CA2849920A1 Methods and compositions for regulating hiv infection |
| 04/11/2013 | CA2849881A1 Pharmaceutical methods and topical compositions containing acitretin |
| 04/11/2013 | CA2849751A1 Novel chiral n-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, methods for use in nk-3 receptor mediated disorders and chiral synthesis thereof |
| 04/11/2013 | CA2849421A1 Malignant and non-malignant disease treatment with ras antagonists |
| 04/11/2013 | CA2849335A1 Methods and systems for identifying and treating anti-progestin sensitive tumors |
| 04/11/2013 | CA2847096A1 Ethynyl derivatives as metabotropic glutamate receptor modulators |
| 04/11/2013 | CA2847095A1 Cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
| 04/11/2013 | CA2846444A1 Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via a novel intermediate |
| 04/11/2013 | CA2846412A1 Treatment of rhinitis |
| 04/11/2013 | CA2846222A1 1-pyrazolyl-3- (4- ( (2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1 - yl) ureas as p38 map kinase inhibitors |
| 04/11/2013 | CA2842881A1 Cysteinyl leukotriene antagonists |
| 04/11/2013 | CA2792079A1 Combination of hyaluronic acid and prilocaine |
| 04/10/2013 | EP2578683A1 Aptamer therapeutics useful in the treatment of complement-related disorders |
| 04/10/2013 | EP2578643A1 Fluorescent dye material and use thereof |
| 04/10/2013 | EP2578603A1 B cell activating factor antagonist and preparation method and use thereof |
| 04/10/2013 | EP2578596A1 Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof |
| 04/10/2013 | EP2578595A1 Levoisovalerylspiramycin i, ii or iii, preparations, preparation methods and uses thereof |
| 04/10/2013 | EP2578591A1 Novel benzoxazine oxazolidinone compounds, preparation methods and uses thereof |
| 04/10/2013 | EP2578590A2 Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases, and pharmaceutical composition containing same |
| 04/10/2013 | EP2578588A1 Novel 1,4-diazepam pde-5 inhibitor derivatives |
| 04/10/2013 | EP2578587A1 Pyrazole derivatives |
| 04/10/2013 | EP2578586A1 HEXAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF |
| 04/10/2013 | EP2578585A1 Purinone derivative |
| 04/10/2013 | EP2578584A1 Arylamino purine derivatives, preparation method and pharmaceutical use thereof |
| 04/10/2013 | EP2578583A1 Fused heterocyclic derivatives and methods of use |
| 04/10/2013 | EP2578582A1 1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 MAP kinase inhibitors |
| 04/10/2013 | EP2578580A1 G, I and K crystal forms of imatinib mesylate |
| 04/10/2013 | EP2578579A1 Benzothiophene carboxamide compounds, composition and applications thereof |
| 04/10/2013 | EP2578578A1 Method for producing (2r)-2-fluoro-2-c-methyl-d-ribono- -lactone precursor |
| 04/10/2013 | EP2578574A1 Optically active dibenzylamine derivative, and manufacturing method for same |
| 04/10/2013 | EP2578573A1 Fused imidazole derivative |